Alopecia areata
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Chinese patients aged 18-50 years are enrolled in this study. They are diagnosed with alopecia areata of stable period according to the clinical features (negative in pull test) and demoscopy. Patients are required to sign the informed consents.
Exclusion criteria
Exclusion criteria: Patients with scalp disorders (such as seborrheic dermatitis, psoriasis or eczema) or other hair diseases(such as androgenetic alopecia, telogen effluvium or anagen effluvium); pregnant or lactating women; allergic to minoxidil; previous topical minoxidil treatment within the past 12 weeks; drug or alcohol abuse; mental diseases or comprehension disorder; undergoing hormonotherapy, phototherapy or physiotherapy; wearing a wig; hair transplantation on the target areas; anemia; ferritin is below 40ug/L; autoimmune diseases; endocrine diseases (such as diabetes, thyroid or pituitary diseases); severe systemic diseases; malignant tumor; hair loss induced by chemotherapeutic drugs; recent craniocerebral operation; participants of other clinical trials within last 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SALT Score for alopecia areata; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sinclair Grade;Dermatology life quality index; | — |
Countries
China
Contacts
Huashan Hospital, Fudan University